Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vinorelbine × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 183 Thoracic 134 Lymphoid 35 Sarcoma 15 Other solid neoplasm 14 Gynecologic 13 Genitourinary 12 Gastrointestinal 8 CNS 8 Other hematologic neoplasm 5 Tumor-Agnostic 4 Plasma cell 3 Dermatologic 3 Endocrine 2 NET 1 Head & Neck 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 550 Radiotherapy 298 pembrolizumab 289 Cetuximab 244 Docetaxel 200 Radiotherapy, Intensity-Modulated 197 Fluorouracil 177 Carboplatin 174 Paclitaxel 148 Nivolumab 127 Gemcitabine 113 Radiation 82 Magnetic Resonance Spectroscopy 81 Drug Therapy 75 toripalimab 68 Capecitabine 67 Surveys and Questionnaires 64 Surgical Procedures, Operative 62 Biopsy 58 durvalumab 55 Blood Specimen Collection 48 Cyclophosphamide 43 Chemoradiotherapy 43 camrelizumab 41 Standard of Care 39 Specimen Handling 39 Erlotinib Hydrochloride 38 Bevacizumab 38 tislelizumab 37 Radiosurgery 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01020864 2020-11-02

CECAVI

Odense University Hospital

Phase 2 Withdrawn

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡